{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:23:48Z","timestamp":1790177028886,"version":"4.1.0"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,9]]},"DOI":"10.18632\/oncotarget.4477","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T04:47:30Z","timestamp":1442292450000},"page":"22822-22835","source":"Crossref","is-referenced-by-count":36,"title":["Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma"],"prefix":"10.18632","volume":"6","author":[{"given":"Daiki","family":"Mochizuki","sequence":"first","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"},{"name":"Department of Otolaryngology\/Head Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy A.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaocheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"},{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Misawa","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\/Head Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"McLean","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"N\u00f6r","sequence":"additional","affiliation":[{"name":"Department of Restorative Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA"},{"name":"Department of Otolaryngology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA"},{"name":"Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, Michigan, USA"},{"name":"Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11864-011-0174-0","article-title":"Recurrent salivary gland cancer","volume":"13","author":"Eisele","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1586\/era.12.92","article-title":"Management of salivary gland tumors","volume":"12","author":"Langendijk","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"3","first-page":"1","article-title":"Review of Salivary Gland Neoplasms","volume":"2012","author":"Wei","year":"2012","journal-title":"ISRN Otolaryngol"},{"key":"4","first-page":"209","article-title":"World Health Organization classification of tumours: pathology and genetics of head and neck in tumours","author":"Reichart P","year":"2005","journal-title":"IARCpress, Lyon"},{"key":"5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semradonc.2012.03.009","article-title":"Biology and management of salivary gland cancers","volume":"22","author":"Hanna","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.pap.0000213058.74509.d3","article-title":"Salivary mucoepidermoid carcinoma: revisited","volume":"13","author":"Luna","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/lary.24238","article-title":"Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome","volume":"123","author":"Donald","year":"2013","journal-title":"Laryngoscope"},{"key":"8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijom.2014.01.008","article-title":"Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population","volume":"43","author":"Wang","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"key":"9","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/cncr.26697","article-title":"Prognostic factors in mucoepidermoid carcinoma of the salivary glands","volume":"118","author":"Kupferman","year":"2012","journal-title":"Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.otohns.2005.08.001","article-title":"Clinical prognostic factors in malignant parotid gland tumors","volume":"133","author":"Salviano","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0002-9610(91)90142-Z","article-title":"The importance of clinical staging of minor salivary gland carcinoma","volume":"162","author":"Strong","year":"1991","journal-title":"Am J Surg"},{"key":"12","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Licitra","year":"2006","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.oraloncology.2012.05.004","article-title":"Systemic therapy in the management of metastatic or advanced salivary gland cancers","volume":"48","author":"Mezlini","year":"2012","journal-title":"Oral Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Pfister","year":"2011","journal-title":"Lancet Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijrobp.2010.09.042","article-title":"Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy","volume":"82","author":"Tishler","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.20327","article-title":"Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group","volume":"28","author":"Forastiere","year":"2006","journal-title":"Head Neck"},{"key":"17","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1172\/JCI32533","article-title":"IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland","volume":"117","author":"Bonaf\u00e8","year":"2007","journal-title":"J Clin Invest"},{"key":"18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/stem.188","article-title":"Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth","volume":"27","author":"McLendon","year":"2009","journal-title":"Stem Cells"},{"key":"19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2013.01.007","article-title":"Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells","volume":"25","author":"Lee","year":"2013","journal-title":"Cell Signal"},{"key":"20","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-09-0287","article-title":"Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis andgrowth of human oral squamous cell carcinoma","volume":"15","author":"Shinohara","year":"2009","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1158\/1078-0432.CCR-10-1095","article-title":"Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer","volume":"16","author":"Duan","year":"2010","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JTO.0000000000000193","article-title":"Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer","volume":"9","author":"Haura","year":"2014","journal-title":"J Thorac Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-12-2353","article-title":"Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma","volume":"73","author":"DeClerck","year":"2013","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-09-3122","article-title":"Clinical and correlative results of SWOG S0354: A phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer","volume":"16","author":"Hussain","year":"2010","journal-title":"Clin Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1158\/0008-5472.CAN-13-0874","article-title":"JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells","volume":"73","author":"Collins","year":"2013","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/cncr.23615","article-title":"Interleukin-6 predicts recurrence and survival among head and neck cancer patients","volume":"113","author":"Teknos","year":"2008","journal-title":"Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1158\/1055-9965.EPI-12-0987","article-title":"Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma","volume":"22","author":"Terrell","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"28","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1158\/0008-5472.CAN-10-1712","article-title":"Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells","volume":"70","author":"N\u00f6r","year":"2010","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/stem.1793","article-title":"Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells","volume":"32","author":"Wicha","year":"2014","journal-title":"Stem Cells"},{"key":"30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1593\/neo.131744","article-title":"Cisplatin induces bmi-1 and enhances the stem cell fraction in head and neck cancer","volume":"16","author":"N\u00f6r","year":"2014","journal-title":"Neoplasia"},{"key":"31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.07815","article-title":"Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling","volume":"10","author":"N\u00f6r","year":"2008","journal-title":"Neoplasia"},{"key":"32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1593\/neo.09266","article-title":"Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3\/Akt\/ERK signaling","volume":"11","author":"N\u00f6r","year":"2009","journal-title":"Neoplasia"},{"key":"33","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1158\/0008-5472.CAN-13-2032","article-title":"Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype","volume":"74","author":"N\u00f6r","year":"2014","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2407-14-99","article-title":"Endothelial cell-derived interleukin-6 regulates tumor growth","volume":"14","author":"N\u00f6r","year":"2014","journal-title":"BMC Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hed.23076","article-title":"Orosphere assay: a method for propagation of head and neck cancer stem cells","volume":"35","author":"N\u00f6r","year":"2013","journal-title":"Head Neck"},{"key":"36","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer","volume":"17","author":"Cummings","year":"2011","journal-title":"Clin Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2000.02093.x","article-title":"A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma","volume":"109","author":"Bataille","year":"2000","journal-title":"Br J Haematol"},{"key":"38","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6605872","article-title":"A phase I\/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer","volume":"103","author":"Berns","year":"2010","journal-title":"Br J Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/pros.21362","article-title":"The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study","volume":"71","author":"Culig","year":"2011","journal-title":"Prostate"},{"key":"40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2011.10.014","article-title":"Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone\/prednisone versus mitoxantrone\/prednisone alone in metastatic castration-resistant prostate cancer","volume":"48","author":"Hudes","year":"2012","journal-title":"Eur J Cancer"},{"key":"41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.24745","article-title":"A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group","volume":"116","author":"Parulekar","year":"2010","journal-title":"Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/1319-3767.80378","article-title":"Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer","volume":"17","author":"Elhawary","year":"2011","journal-title":"Saudi J Gastroenterol"},{"key":"43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-12-26","article-title":"IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus","volume":"12","author":"Lee","year":"2013","journal-title":"Mol Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/0008-5472.CAN-04-2425","article-title":"Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice","volume":"65","author":"Arlinghaus","year":"2005","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"Weng","year":"2009","journal-title":"Cancer Cell"},{"key":"46","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-06-0861","article-title":"Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer","volume":"12","author":"Seiden M","year":"2006","journal-title":"Clin Cancer Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2013.08.004","article-title":"Interleukin-6: An angiogenic target in solid tumours","volume":"89","author":"Coward","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.oraloncology.2013.08.004","article-title":"Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma","volume":"49","author":"Castilho","year":"2013","journal-title":"Oral Oncol"},{"key":"49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Boyd","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1158\/1535-7163.MCT-08-1078","article-title":"TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis","volume":"8","author":"N\u00f6r","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/labinvest.3780253","article-title":"Engineering and characterization of functional human microvessels in immunodeficient mice","volume":"81","author":"Polverini","year":"2001","journal-title":"Lab Invest"},{"key":"52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65284-4","article-title":"Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression","volume":"154","author":"Polverini","year":"1999","journal-title":"Am J Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T13:56:20Z","timestamp":1589378180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,15]]},"references-count":52,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,9,9]]}},"alternative-id":["4477","26287605"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4477","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,15]]}}}